Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University
Wuhan, Hubei, 430062, China
NCT Number: NCT05808140
In endoscopic spinal nerve root decompression surgery, the intraoperative nerve exploration is time-consuming and critical. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Damage to nerve roots may lead to postoperative sensory retardation and motor weakness, thereby impairing the physical function of patients. A real-time auxiliary intraoperative nerve identification technology is necessary.
In this prospective, open-label, randomized, parallel controlled trial, 40 patients who undergo endoscopic spinal surgery are included. Subjects are randomly divided into control group and low, medium and high Indocyanine green(ICG) preoperative administration experimental group. Standard endoscopic spinal surgery is performed in the control group. Patients in the experimental group received an intravenous injection of ICG before surgery, and a standard endoscopic spinal surgery is performed with the use of a fluoroscopic endoscopic surgical imaging system to assist the surgeon in identifying and protecting the nerve roots.
The main objectives of this experiment are (i) to explore the safety and feasibility of ICG fluorescence imaging to assist in nerve root identification during endoscopic spinal surgery and (ii) the effectiveness of this technique for endoscopic search for nerve roots. The secondary objective is to explore the optimal ICG dosing regimen.
Looking for future studies?
Notify Me20 year–60 year
All sexes
Interventional
Phase 1 / Phase 2
Wuhan, Hubei, 430062, China
With the accelerated pace of the global aging society, the prevalence of degenerative diseases is increasing. At present, spinal degenerative diseases caused by body degeneration have become the most common type. With the continuous deepening of the research on spinal degenerative diseases and the continuous development, update and promotion of minimally invasive surgery technology and instruments, minimally invasive surgery has attracted more and more attention of spine surgeons due to its advantages of rapid recovery, small trauma and fewer complications.
The core of endoscopic spinal surgery is nerve root decompression. The procedure is centered on the nerve roots, which can be damaged with the slightest carelessness. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Most of the injuries include the stimulation and edema of the nerve root during the operation, which may lead to postoperative sensory retardation and motor weakness, which will damage the patient's physical function and reduce overall satisfaction. The intraoperative nerve exploration is time-consuming and critical, and the variability of the patient's nerve anatomy will also add difficulties to the operation. A real-time auxiliary intraoperative nerve identification technology is necessary.
With the progress of optical technology, fluorescent-guided surgery has shown considerable prospects in assisting in identifying nerves. Indocyanine green (ICG) is the only fluorophore approved by the US Food and Drug Administration (FDA) for intraoperative near-infrared imaging. It can emit near-infrared light after being irradiated by excitation light, which has the characteristics of high penetration depth, low spontaneous fluorescence and high sensitivity. At present, ICG near-infrared fluorescence imaging has been applied to tumor detection, lymphangiography and vascular perfusion evaluation. In recent years, more and more researchers have paid attention to the application value of ICG fluorescence imaging in neuroimaging. It has been applied to clinical research of thoracic sympathetic ganglion, facial nerve, phrenic nerve and pelvic nerve.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Preoperatively, a single dose of intravenous indocyanine green is administered
Other names: ICG
Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively
Time frame: Intraoperative
Number of the nerve roots with fluorescent imaging in the experimental group/Total nerve roots in the experimental group×100%
Time frame: Immediately postoperative
Nerve root fluorescence intensity/Background fluorescence intensity
Time frame: Intraoperative
Time from opening the ligamentum flavum to finding the nerve root in spinal endoscopic procedures
Time frame: Immediately after ICG administration to 30 min after administration
Time frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery
The VAS pain score uses the VAS scale, with end 0 being no pain, graded 1-4 being mild pain, 5-6 being moderate pain, 7-9 being severe pain, and end 10 being unbearable pain. The higher the score, the more severe the pain level.
Time frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery
The ODI score is based on the Oswestry Disability Index questionnaire. The lowest score was 0% and the highest score was 100%, with higher scores indicating more severe functional impairment.
Time frame: Within 1 week after surgery
Record any surgical complications that occurred in the patient within 1 week after surgery
Time frame: From the beginning to the end of the surgery
Use a timer to record the length of the surgery (accurate to the minute)
Zhongnan Hospital
Other
Clinical Application of Indocyanine Green Fluorescence Imaging to Assist Identification of Nerve Roots in Endoscopic Spinal Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06615518
Bone Diseases, Disc Herniation
Opole, Opole Voivodeship, Poland
View Trial DetailsNCT07261020
Anxiety Disorders, Back Pain
Istanbul, Kadıköy, Turkey (Türkiye)
View Trial DetailsNCT06006377
Back Pain, Bone Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05999565
Bone Diseases, Disc Herniation
Yozgat, Turkey (Türkiye)
View Trial Details